Apoptosis. Its significance in cancer and cancer Therapy

Cancer

Volumn 73, Issue 8, 1994, Pages 2013-2026

  Kerr, John F R ^a   Winterford, Clay M ^a   Harmon, Brian V ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

anti cancer drugs; apoptosis; cell deletion; DNA fragmentation; hormone ablation; hyperthermia; programmed cell death; proto oncogene; radiation; tumor suppressor gene

Indexed keywords

DOUBLE STRANDED DNA; MESSENGER RNA;

APOPTOSIS; CANCER THERAPY; DNA STRAND; ETIOLOGY; GENE INDUCTION; GENETIC REGULATION; HUMAN; HYPERTHERMIA; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMAL; APOPTOSIS; HUMAN; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; SUPPORT, NON-U.S. GOV'T;

EID: 0028329172     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J     Document Type: Article

References (179)

1. Social controls on cell survival and cell death
2. Programmed cell death: apoptosis and oncogenesis
3. Cell death studies yield cancer clues
4. A suggested explanation for the paradoxically slow growth rate of basal‐cell carcinomas that contain numerous mitotic figures
5. Apoptosis: a basic biological phenomenon with wide‐ranging implications in tissue kinetics
6. Apoptosis: its nature and kinetic role
7. Apoptosis in irradiated murine tumors
8. Cellular kinetics, dosimetry, and radiobiology of α‐particle radioimmunotherapy: induction of apoptosis
9. An electron‐microscope study of the mode of cell death induced by cancer‐chemotherapeutic agents in populations of proliferating normal and neoplastic cells
10. Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia
11. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
12. Drug‐target interactions: only the first step in the commitment to a programmed cell death?
13. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1‐β‐D‐arabinofuranosylcytosine
14. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle
15. + prolymphocytic leukemia by deoxyadenosine and 2'‐deoxycoformycin
16. Cell death induced in a murine mastocytoma by 42–47dC heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load
17. The role of apoptosis in the response of cells and tumours to mild hyperthermia
18. Apoptosis induced by mild hyperthermia in human and murine tumour cell lines: a study using electron microscopy and DNA gel electrophoresis
19. Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone‐releasing hormone antagonist SB‐75
20. Programmed cell death during regression of the MCF‐7 human breast cancer following estrogen ablation
21. Sustained release formulations of luteinizing hormone‐releasing hormone antagonist SB‐75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC‐82) in male nude mice
22. Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression
23. Cascade induction of c‐fos c‐myc and heat shock 70K transcripts during regression of the rat ventral prostate gland
24. Bcl‐2 gene promotes haemopoietic cell survival and cooperates with c‐myc to immortalize pre‐B cells
25. Bcl‐2 is an inner mitochondrial membrane protein that blocks programmed cell death
26. Constitutive c‐myc expression in an IL‐3‐dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis
27. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death
28. Wild‐type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin‐6
29. Involvement of bcl‐2 in glucocorticoid‐induced apoptosis of human pre‐B‐leukemias
30. Apoptotic cell death induced by c‐myc is inhibited by bcl‐2
31. Expression and involvement of c‐fos and c‐jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines
32. Induction of apoptosis in fibroblasts by c‐myc protein
33. Cooperative interaction between c‐myc and bcl‐2 proto‐oncogenes
34. Bcl‐2 initiates a new category of oncogenes: regulators of cell death
35. Bcl‐2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
36. Induction of apoptosis by wild‐type p53 in a human colon tumor‐derived cell line
37. Role for c‐myc in activation‐induced apoptotic cell death in T cell hybridomas
38. Bcl‐2 prevents death of factor‐deprived cells but fails to prevent apoptosis in targets of cell mediated killing
39. Bcl‐2 blocks apoptosis in cells lacking mitochondrial DNA
40. Glucocorticoid‐induced thymocyte apoptosis is associated with endogenous endonuclease activation
41. Cell death: the significance of apoptosis
42. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance
43. Endogenous endonuclease‐induced DNA fragmentation: an early event in cell‐mediated cytolysis
44. Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death
45. Death and the cell
46. Cell death
47. Patterns of cell death
48. Programmed cell death in the immune system
49. Apoptosis: molecular mechanisms in programmed cell death
50. Cell death mechanisms and the immune system
51. Definition and incidence of apoptosis: an historical perspective
52. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview
53. Apoptosis
54. Apoptosis: mechanisms and roles in pathology
55. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats
56. Activation of programmed cell death in the rat ventral prostate after castration
57. Biochemical evidence for programmed cell death in rabbit uterine epithelium
58. Induction of DNA fragmentation in chronic B‐lymphocytic leukemia cells
59. 1 induces apoptotic cell death in cultured human gastric carcinoma cells
60. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation
61. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis
62. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes
63. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation
64. Glucocorticoid activation of a calcium‐dependent endonuclease in thymocyte nuclei leads to cell death
65. 2+‐requiring mechanism(s)
66. Apoptosis: the role of the endonuclease
67. Identification and characterization of gluco‐corticoid‐regulated nuclease(s) in lymphoid cells undergoing apoptosis
68. 2B
69. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis
70. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death)
71. Mitochondrial DNA is not fragmented during apoptosis
72. Teniposide induces nuclear but not mitochondrial DNA degradation
73. Hormone‐induced cell death: purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment
74. Cytolysis induced by human lymphotoxin: cinemicrographic and electron microscopic observations
75. The mechanism of T cell mediated cytotoxicity: II. morphological studies of cell death by time‐lapse microcinematography
76. Microcinematographic and electron microscopic analysis of target cell lysis induced by cytotoxic T lymphocytes
77. Tubulin in apoptotic cells
78. Microfilament‐disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis
79. Induction and activation of tissue transglutaminase during programmed cell death
80. Searching for the function of tissue transglutaminase: its possible involvement in the biochemical pathway of programmed cell death
81. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action
82. The expression of ‘tissue’ transglutaminase in two human cancer cell lines is related with programmed cell death (apoptosis)
83. ‘Tissue’ transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor‐stimulation
84. Active cell death in hormone‐dependent tissues
85. Phagocyte recognition of cells undergoing apoptosis
86. Macrophage recognition of cells undergoing programmed cell death (apoptosis)
87. Vitronectin receptor‐mediated phagocytosis of cells undergoing apoptosis
88. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis
89. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
90. Induction of the TRPM‐2 gene in cells undergoing programmed death
91. Differential expression of clusterin in inducible models of apoptosis
92. Identification of mRNAs associated with programmed cell death in immature thymocytes
93. Identification of genes involved in programmed cell death
94. Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death
95. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis
96. Gene induction by γ‐irradiation leads to DNA fragmentation in lymphocytes
97. Activation‐induced cell death in T cell hybridomas is due to apoptosis
98. IL3‐dependent cells die by apoptosis on removal of their growth factor
99. DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels
100. Induction of apoptosis (programmed cell death) in human leukemic HL‐60 cells by inhibition of RNA or protein synthesis
101. Effects of cycloheximide on B‐chronic lymphocytic leukaemic and normal lymphocytes in vitro: induction of apoptosis
102. Apoptosis: mode of cell death induced in T cell leukemia lines by dexamethasone and other agents
103. 2+‐mediated endonuclease activation
104. Activation‐driven T cell death: I. requirements for de novo transcription and translation and association with genome fragmentation
105. The effect of cycloheximide on natural and x‐ray‐induced cell death in the developing cerebral cortex
106. Cellular signalling in programmed cell death (apoptosis)
107. Dexamethasone‐induced killing of neoplastic cells of lymphoid derivation: lack of early calcium involvement
108. 2+ are not required to trigger apoptosis in human leukaemia cells
109. Induction of apoptosis: new targets for cancer chemotherapy
110. An electron‐microscope study of cell deletion in the anuran tadpole tail during spontaneous metamorphosis with special reference to apoptosis of striated muscle fibres
111. Shrinkage necrosis: a distinct mode of cellular death
112. Preferential distribution of apoptotic bodies in acinar zone 3 of the normal human and rat liver
113. Deletion of cells by apoptosis during castration‐induced involution of the rat prostate
114. Adrenocortical cell deletion: the role of ACTH
115. Extreme sensitivity of some intestinal crypt cells to X and γ irradiation
116. Cell death in spermatogenesis
117. Hormonal control of apoptosis in hamster uterine luminal epithelium
118. IL‐2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells
119. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis
120. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation
121. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinflammatory cytokines
122. Insulin‐like growth factor I inhibits apoptosis in IL‐3‐dependent hemopoietic cells
123. Evidence for soluble factors regulating cell death and cell proliferation in primary cultures of rabbit endometrial cells grown on collagen
124. Cell death by apoptosis during involution of the lactating breast in mice and rats
125. Ultrastructural changes in the theca interna during follicular atresia in sheep
126. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia
127. Apoptosis as the mechanism of the involution of hair follicles in catagen transformation
128. Antibodies to CD3/T‐cell receptor complex induce cell death by apoptosis in immature T cells in thymic cultures
129. Mechanism of antigen‐driven selection in germinal centres
130. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages
131. Fate of senescent megakaryocytes in the bone marrow
132. The spontaneous occurrence of apoptosis in squamous carcinomas of the uterine cervix
133. The biology of cell death in tumours
134. An ultrastructural study of spontaneous cell death in a mouse mastocytoma with particular reference to dark cells
135. Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours
136. Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy
137. 2+ concentration and DNA fragmentation
138. Apoptosis and DNA fragmentation precede TNF‐induced cytolysis in U937 cells
139. Spontaneous regression in basal cell carcinomas
140. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters
141. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells: a sequential study
142. Cell death by apoptosis following X‐irradiation of the foetal and neonatal rat kidney
143. Ultrastructural changes in lymphocytes exposed to noxious agents in vitro
144. Radiation‐induced interphase death of rat thymocytes is internally programmed (apoptosis)
145. Apoptosis and programmed cell death in immunity
146. Ultrastructural radiation injury of rat parotid gland: a histopathologic dose‐response study
147. Response of parotid gland organ culture to radiation
148. The relationship between apoptosis and atrophy in the irradiated lacrimal gland
149. Quantitative histological changes in a human melanoma xenograft following exposure to single dose irradiation and hyperthermia
150. 32P induces massive apoptosis in a Burkitt's lymphoma cell line
151. p53, guardian of the genome
152. Thymocyte apoptosis induced by p53‐dependent and independent pathways
153. p53 is required for radiation‐induced apoptosis in mouse thymocytes
154. The topoisomerase II inhibitor teniposide (VM‐26) induces apoptosis in unstimulated mature murine lymphocytes
155. Apoptosis induced by anticancer drugs
156. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents
157. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells
158. Bcl‐2 modulation of apoptosis induced by anti‐cancer drugs: resistance to thymidylate stress is independent of classical resistance pathways
159. The effect of hyperthermia on the neuro‐epithelium of the 21‐day guinea‐pig foetus: histologic and ultrastructural study
160. The morphologic categorization of cell death induced by mild hyperthermia and comparison with death induced by ionizing radiation and cytotoxic drugs
161. Hyperthermia induces apoptosis in thymocytes
162. Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids
163. Expression of the protooncogene bcl‐2 in the prostate and its association with emergence of androgen‐in‐dependent prostate cancer
164. Monoclonal antibody‐mediated tumor regression by induction of apoptosis
165. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
166. Purification and molecular cloning of the APO‐1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen
167. Apoptosis in the APO‐1 system
168. Induction of apoptosis by monoclonal antibody anti‐APO‐1 class switch variants is dependent on cross‐linking of APO‐1 cell surface antigens
169. Death of cells by apoptosis following attachment of specifically allergized lymphocytes in vitro
170. Mechanisms of immune lysis III: characterization of the nature and kinetics of the cytotoxic T lymphocyte‐induced nuclear lesion in the target
171. The mechanism of K cell (antibody‐dependent) cell mediated cytotoxicity II: characteristics of the effector cell and morphological changes in the target cell
172. The role of natural killer cells in the intravascular death of intravenously injected murine tumour cells
173. An electron microscopic study of the mode of donor cell death in unmodified rejection of pig liver allografts
174. CTL: virus control cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis
175. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions
176. Continuous c‐fos expression precedes programmed cell death in vitro
177. p53: the ultimate tumor suppressor gene?
178. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
179. A death in the life of p53